CTOs on the Move

gfm corporation

www.gfmcorp.com

 
gfm corporation is a Roseville, MI-based company in the Manufacturing sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.gfmcorp.com
  • 15585 Sturgeon St
    Roseville, MI USA 48066
  • Phone: 586.777.4542

Executives

Name Title Contact Details

Similar Companies

Syndicate Sales Inc

Syndicate Sales Inc is one of the leading companies in Manufacturing industry. Syndicate Sales Inc is based in Kokomo, IN. You can find more information on Syndicate Sales Inc at www.syndicatesales.com

CEIS

CEIS is a company that offers a wide range of solutions for energy customers, including clearance required services for the Department of Energy and power generation companies.

Kind and Knox Gelatin Inc

Kind and Knox Gelatin Inc is a Sergeant Bluff, IA-based company in the Manufacturing sector.

Dorsett Brothers Concrete Supply

Dorsett Brothers Concrete Supply is a Pasadena, TX-based company in the Manufacturing sector.

enVVeno

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.